Edgewise Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EWTX and other ETFs, options, and stocks.

About EWTX

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.

CEO

Kevin Koch

CEOKevin Koch

Employees

Employees88

Headquarters

Boulder, Colorado

HeadquartersBoulder, Colorado

Founded

2017

Founded2017

Employees

Employees88

EWTX Key Statistics

Market cap

3.06B

Market cap3.06B

Price-Earnings ratio

-21.51

Price-Earnings ratio-21.51

Dividend yield

—

Dividend yield—

Average volume

544.08K

Average volume544.08K

High today

$33.94

High today$33.94

Low today

$32.07

Low today$32.07

Open price

$32.93

Open price$32.93

Volume

322.59K

Volume322.59K

52 Week high

$38.12

52 Week high$38.12

52 Week low

$5.93

52 Week low$5.93

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

Edgewise Therapeutics

Why Robinhood?

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Show more

EWTX Key Statistics

Analyst ratings

100%

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.